From: Role of multislice computed tomography 3D volumetric analysis in the assessment of the therapeutic response of hepatocellular carcinoma after transarterial chemoembolization
Count
Percentage
mRECIST
CR
3
6.0%
PR
11
22.0%
SD
35
70.0%
PD
1
2.0%
Responder
14
28.0%
Nonresponder
36
72.0%
vRECIST
38
76.0%
12
24.0%